Real-time enrollment status for this sjogren's disease clinical trial
Current Status
Active, Not Recruiting
Checked: April 17, 2026 at 6:34 AM UTC
| NCT Number | NCT06928142 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Sjogren's Disease |
| Phase | Clinical Trial |
| Target Enrollment | 80 participants |
| Active Locations | 18 sites in the US |
| Sponsor | Otsuka Pharmaceutical Development & Commercialization, Inc. |
| Last Updated on CT.gov | March 18, 2026 (Mar 18, 2026) |
As of April 17, 2026: Clinical trial NCT06928142 is currently active_not_recruiting participants. This clinical trial study for sjogren's disease is not currently accepting new participants at 18 locations across the United States. The study is sponsored by Otsuka Pharmaceutical Development & Commercialization, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT06928142 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 18 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06928142 was last updated Mar 18, 2026 (March 18, 2026). HelloStudys verifies this status automatically.